Works by Li, Chunze

Results: 58
    1
    2
    3
    4

    Oncology Dose Optimization: Tailored Approaches to Different Molecular Classes.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 1, p. 74, doi. 10.1002/cpt.3658
    By:
    • Zhu, Jiawen;
    • Schroeder, Amy;
    • Frank, Sabine;
    • Boetsch, Christophe;
    • Jamois, Candice;
    • Kassir, Nastya;
    • Korfi, Koorosh;
    • Punnoose, Elizabeth;
    • Vaze, Anjali;
    • Trask, Peter;
    • Gosai, Pritti;
    • Fridlyand, Jane;
    • Li, Chunze
    Publication type:
    Article
    5

    A Novel Step‐Up Dosage Regimen for Enhancing the Benefit‐to‐Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 465, doi. 10.1002/cpt.3445
    By:
    • Li, Chi‐Chung;
    • Bender, Brendan;
    • Wilkins, Justin;
    • Li, Feifei;
    • Turner, David C.;
    • Wang, Bei;
    • Deng, Rong;
    • Vadhavkar, Shweta;
    • Li, Zao;
    • Kwan, Antonia;
    • Huang, Huang;
    • Peng, Kun;
    • Penuel, Elicia;
    • Huw, Ling‐Yuh;
    • Chanu, Pascal;
    • Li, Chunze;
    • Yin, Shen;
    • Wei, Michael C.
    Publication type:
    Article
    6
    7

    Risk‐Based Pharmacokinetic and Drug–Drug Interaction Characterization of Antibody–Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development Perspective.

    Published in:
    Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 4, p. 754, doi. 10.1002/cpt.2448
    By:
    • Li, Chunze;
    • Menon, Rajeev;
    • Walles, Markus;
    • Singh, Renu;
    • Upreti, Vijay V.;
    • Brackman, Deanna;
    • Lee, Anthony J.;
    • Endres, Christopher J.;
    • Kumar, Seema;
    • Zhang, Donglu;
    • Barletta, Frank;
    • Suri, Ajit;
    • Hainzl, Dominik;
    • Liao, Kai H.;
    • Lalovic, Bojan;
    • Beaumont, Maribel;
    • Zuo, Peiying;
    • Mayer, Andrew P.;
    • Wei, Dong
    Publication type:
    Article
    8
    9

    Strategies and Recommendations for Using a Data‐Driven and Risk‐Based Approach in the Selection of First‐in‐Human Starting Dose: An International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Assessment.

    Published in:
    Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1395, doi. 10.1002/cpt.2009
    By:
    • Leach, Michael W.;
    • Clarke, David O.;
    • Dudal, Sherri;
    • Han, Chao;
    • Li, Chunze;
    • Yang, Zheng;
    • Brennan, Frank R.;
    • Bailey, Wendy J.;
    • Chen, Yingxue;
    • Deslandes, Antoine;
    • Loberg, Lise I.;
    • Mayawala, Kapil;
    • Rogge, Mark C.;
    • Todd, Marque;
    • Chemuturi, Nagendra V.
    Publication type:
    Article
    10
    11
    12

    Population pharmacokinetic and exploratory exposure–response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 499, doi. 10.1007/s00280-021-04296-0
    By:
    • Wang, Bei;
    • Deng, Rong;
    • Hennig, Stefanie;
    • Badovinac Crnjevic, Tanja;
    • Kaewphluk, Monika;
    • Kågedal, Matts;
    • Quartino, Angelica L.;
    • Girish, Sandhya;
    • Li, Chunze;
    • Kirschbrown, Whitney P.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Exposure–response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 1, p. 56, doi. 10.1080/10428194.2019.1657575
    By:
    • Deng, Rong;
    • Gibiansky, Leonid;
    • Lu, Tong;
    • Li, Xiaobin;
    • Lu, Dan;
    • Li, Chunze;
    • Girish, Sandhya;
    • Wang, Jue;
    • Boyer, Michelle;
    • Shankar, Noopur;
    • Humphrey, Kathryn;
    • Freise, Kevin J.;
    • Salem, Ahmed Hamed;
    • Seymour, John F.;
    • Kater, Arnon P.;
    • Miles, Dale
    Publication type:
    Article
    28
    29
    30
    31

    Application of a Two-Analyte Integrated Population Pharmacokinetic Model to Evaluate the Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Polatuzumab Vedotin in Patients with Non-Hodgkin Lymphoma.

    Published in:
    Pharmaceutical Research, 2020, v. 37, n. 12, p. 1, doi. 10.1007/s11095-020-02933-6
    By:
    • Lu, Dan;
    • Lu, Tong;
    • Shi, Rong;
    • Gibiansky, Leonid;
    • Agarwal, Priya;
    • Shemesh, Colby S.;
    • Dere, Randall C.;
    • Ogbu, Uzor;
    • Hirata, Jamie;
    • Chanu, Pascal;
    • Girish, Sandhya;
    • Jin, Jin Yan;
    • Li, Chunze;
    • Miles, Dale
    Publication type:
    Article
    32
    33

    Bayesian Population Model of the Pharmacokinetics of Venetoclax in Combination with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from the Phase III MURANO Study.

    Published in:
    2019
    By:
    • Deng, Rong;
    • Gibiansky, Leonid;
    • Lu, Tong;
    • Agarwal, Priya;
    • Ding, Hao;
    • Li, Xiaobin;
    • Kshirsagar, Smita;
    • Lu, Dan;
    • Li, Chunze;
    • Girish, Sandhya;
    • Wang, Jue;
    • Boyer, Michelle;
    • Humphrey, Kathryn;
    • Freise, Kevin J.;
    • Salem, Ahmed Hamed;
    • Seymour, John F.;
    • Kater, Arnon P.;
    • Miles, Dale
    Publication type:
    journal article
    34
    35
    36

    Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma.

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 3, p. 844, doi. 10.1007/s10637-019-00832-1
    By:
    • Sandhu, Shahneen;
    • McNeil, Catriona M.;
    • LoRusso, Patricia;
    • Patel, Manish R.;
    • Kabbarah, Omar;
    • Li, Chunze;
    • Sanabria, Sandra;
    • Flanagan, W. Michael;
    • Yeh, Ru-Fang;
    • Brunstein, Flavia;
    • Nazzal, Denise;
    • Hicks, Rodney;
    • Lemahieu, Vanessa;
    • Meng, Raymond;
    • Hamid, Omid;
    • Infante, Jeffrey R.
    Publication type:
    Article
    37

    Ethnic Sensitivity Assessment of Mosunetuzumab Pharmacokinetics and Pharmacodynamics in Chinese Patients With Relapsed or Refractory Follicular Lymphoma.

    Published in:
    CTS: Clinical & Translational Science, 2025, v. 18, n. 5, p. 1, doi. 10.1111/cts.70211
    By:
    • Li, Junyi;
    • Liao, Michael Z.;
    • Wilkins, Justin;
    • Penuel, Elicia;
    • Wang, Bei;
    • Vadhavkar, Shweta;
    • Peng, Kun;
    • Cao, Junning;
    • Li, Zhiming;
    • Zhang, Ye;
    • Li, Wenjin;
    • Li, Donghang;
    • Zhou, Mingzhu;
    • Wei, Michael C.;
    • Kwan, Antonia;
    • Zhao, Rong;
    • Li, Chunze;
    • Li, Chi‐Chung;
    • Turner, David C.
    Publication type:
    Article
    38
    39
    40
    41
    42

    Pharmacokinetics of biologics in gastric cancer.

    Published in:
    CTS: Clinical & Translational Science, 2023, v. 16, n. 4, p. 564, doi. 10.1111/cts.13474
    By:
    • Li, Junyi;
    • Turner, David C.;
    • Li, Feifei;
    • Chen, Xi;
    • Liao, Michael Z.;
    • Li, Chunze
    Publication type:
    Article
    43

    Prediction of Human Pharmacokinetics of Antibody–Drug Conjugates From Nonclinical Data.

    Published in:
    CTS: Clinical & Translational Science, 2019, v. 12, n. 5, p. 534, doi. 10.1111/cts.12649
    By:
    • Li, Chunze;
    • Zhang, Cindy;
    • Deng, Rong;
    • Leipold, Douglas;
    • Li, Dongwei;
    • Latifi, Brandon;
    • Gao, Yuying;
    • Zhang, Crystal;
    • Li, Zao;
    • Miles, Dale;
    • Chen, Shang‐Chiung;
    • Samineni, Divya;
    • Wang, Bei;
    • Agarwal, Priya;
    • Lu, Dan;
    • Prabhu, Saileta;
    • Girish, Sandhya;
    • Kamath, Amrita V.
    Publication type:
    Article
    44

    Discovery of a Potent, CNS-Penetrant Orexin Receptor Antagonist Based on an N, N-Disubstituted-1,4-diazepane Scaffold that Promotes Sleep in Rats.

    Published in:
    ChemMedChem, 2009, v. 4, n. 7, p. 1069, doi. 10.1002/cmdc.200900069
    By:
    • Whitman, David B.;
    • Cox, Christopher D.;
    • Breslin, Michael J.;
    • Brashear, Karen M.;
    • Schreier, John D.;
    • Bogusky, Michael J.;
    • Bednar, Rodney A.;
    • Lemaire, Wei;
    • Bruno, Joseph G.;
    • Hartman, George D.;
    • Reiss, Duane R.;
    • Harrell, C. Meacham;
    • Kraus, Richard L.;
    • Li, Yuxing;
    • Garson, Susan L.;
    • Doran, Scott M.;
    • Prueksaritanont, Thomayant;
    • Li, Chunze;
    • Winrow, Christopher J.;
    • Koblan, Kenneth S.
    Publication type:
    Article
    45
    46
    47
    48
    49
    50